13G Filing: 683 Capital Partners and Galmed Pharmaceuticals Ltd (GLMD)

Page 7 of 9 – SEC Filing

(c)
Number of shares as to which such person has:
(i)            Sole power to vote or to direct the vote of Ordinary Shares:
See Cover Pages Items 5-9.
(ii)           Shared power to vote or to direct the vote of Ordinary Shares:
See Cover Pages Items 5-9.
(iii)          Sole power to dispose or to direct the disposition of Ordinary Shares:
See Cover Pages Items 5-9.
(iv)          Shared power to dispose or to direct the disposition of Ordinary Shares:
See Cover Pages Items 5-9.
Item 5.
Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the date hereof the Reporting Persons have ceased to be the beneficial owner of more than five percent of the class of securities, check the following [   ].
Item 6.
Ownership of More than Five Percent on Behalf of Another Person.
Not applicable.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.
Not applicable.
Item 8.
Identification and Classification of Members of the Group.
See Exhibit A.
Item 9.
Notice of Dissolution of Group.
Not applicable.
Item 10.
Certification.
By signing below the undersigned certifies that, to the best of its or his knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

Follow Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD)